# Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease

> **NCT01932203** · PHASE4 · UNKNOWN · sponsor: **Inha University Hospital** · enrollment: 255 (actual)

## Conditions studied

- Cerebral Small Vessel Disease

## Interventions

- **DRUG:** aspirin
- **DRUG:** cilostazol

## Key facts

- **NCT ID:** NCT01932203
- **Lead sponsor:** Inha University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07-17
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-31
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2019-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932203, "Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01932203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*